Kind Meds (Cannabis Education Blog)

JUNE 27, 2021

At the same time, the pharmaceutical industry has become one of the most powerful businesses in the country. Big Pharma, which includes ten of the largest powers of the pharmaceutical industry, like businesses such as Johnson & Johnson, are heavily influential when it comes to political decisions in the U.S. Epilepsy and seizures.

Pharmaceutical 99

Pharmaceutical Chronic Pain Medicine Nerve Pain 99

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. In 2020, the law changed to allow patients with any medical condition to receive a doctor’s recommendation to use and purchase medical marijuana products containing a maximum 10 milligrams of THC.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The use of ones containing THC was legalised across the UK in November 2018.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

The Cannigma

MARCH 7, 2022

So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. Long before THC was discovered in the 1940s , CBN was first identified at the turn of the 20th century from a plant that was then known as Indian hemp. Converting THC to CBN happens through oxidation.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

JULY 30, 2019

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. The US approval of Zogenix’s Fintepla, a potential competitor for GW’s drug, has been delayed but still lo… The European Pharmaceutical Review reports.

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

MMJ Recs

APRIL 1, 2024

Unlike its counterpart THC (tetrahydrocannabinol), CBD doesn’t produce psychoactive effects, making it an attractive option for those seeking therapeutic relief without the “high” associated with traditional marijuana use.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Otherside Farms

JANUARY 24, 2019

Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. Although both studies will enroll 25 patients initially, the U.S. Source: FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials. In the upcoming U.S.

Clinical Trials 45

Clinical Trials Epilepsy Marijuana Pharmaceutical 45

Cannabis Law Report

NOVEMBER 29, 2019

Tetrahydrocannabinol (THC) is the element in cannabis that gets a person high. THC is the psychoactive compound in cannabis. But, THC has a similar chemical makeup with cannabidiol or CBD. CBD combats THC’s effects. THC alters communication functions. That’s why some people choose THC oil. THC Oil Benefits.

Oil 104

Oil THC Cannabinoids Research and Development 104

MMJ Recs

FEBRUARY 18, 2024

Patients often report improvements in the specific symptoms they sought to alleviate and their overall sense of well-being. Research has identified cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol) as key players in the plant’s therapeutic effects.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

United Patients Group

APRIL 18, 2023

Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! In fact, there are some patients who prefer not to smoke because of their health conditions or other reasons. Myth: Cannabis is a cure-all.

Research and Development 108

Research and Development Indica Treatment Conditions 108

Cannabis Law Report

AUGUST 4, 2022

Following the keenly anticipated June approval of its cannabis-derived Epidiolex, GW Pharmaceuticals $GWPH has finally launched the rare epilepsy drug in the United States. of tetrahydrocannabinol (THC), the component renowned for its ability to get people high. Press Release.

Epilepsy 52

Epilepsy Therapy Patients Treatment 52

MGC Pharma

DECEMBER 12, 2017

A word from Elad Segev, Manager of Breeding and Cultivation at MGC Pharmaceuticals. Tetrahydrocannabinol (THC) Tetrahydrocannabinol, or THC, is the component of the Cannabis plant that produces psychoactive effects that can range from racing thoughts to paranoia. You can learn more about that here.

Epilepsy 100

Epilepsy Cannabinoids Pharmaceutical THC 100

Cannabis Law Report

JULY 7, 2022

filed a petition requesting inter partes review of claims 1-13 of GW Pharmaceutical Ltd.’s s patent directed to the use of cannabinoids, including cannabidiol (“CBD”), in the treatment of certain types of epilepsy. The prior art asserted was clinical literature involving administration of CBD or tetrahydrocannabinol (“THC”).

Epilepsy 52

Epilepsy Pharmaceutical Treatment Cannabinoids 52

Veriheal

JULY 5, 2021

Cannabis is brimming with hundreds of active cannabinoids, but just two have really managed to steal the limelight – THC (tetrahydrocannabinol) and CBD (cannabidiol). sales last year—a recent study has confirmed that these cannabinoid receptor-binding molecules offer different levels of symptomatic relief for nausea patients. .

THC 52

THC CBD Treatment Cannabinoids 52

Cannabis Law Report

APRIL 20, 2022

WROCLAW, Poland , April 19, 2022 /PRNewswire/ — Can4Med , a licensed wholesale specializing in medical products containing THC and cannabinoids has obtained Polish authorization to supply medical products and raw materials for cannabis pharmaceutical sales. About Can4Med.

Pharmaceutical 52

Pharmaceutical Patients Medicine Epilepsy 52

Cannabis Law Report

JULY 24, 2019

Our clinics are based on the premise that patients are treated by our world-renowned specialists in the relevant condition. We have the expertise to prescribe medicinal cannabis in a way that fits in with other more conventional treatments as and when we judge that to be in the best interest of the patients.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

United Patients Group

FEBRUARY 2, 2023

The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). The cannabinoids found within cannabis have been shown to help boost our natural defenses against illness by improving our overall health status rather than just treating symptoms like most pharmaceuticals do (i.e.,

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

Cannabis Law Report

JANUARY 16, 2022

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

MMJ Recs

JANUARY 6, 2024

In recent years, the landscape of medical marijuana has evolved dramatically, offering patients a diverse array of products tailored to address a myriad of health conditions. Capsules and pills provide a familiar oral ingestion method, akin to traditional pharmaceuticals.

Chronic Pain 52

Chronic Pain Topical Marijuana Indica 52

Canna Care Docs

SEPTEMBER 18, 2020

Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication. Patients may purchase medical cannabis in oil-based preparations such as lozenges, capsules, and vape pens. Can a Qualifying Patient Grow Cannabis in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Veriheal

SEPTEMBER 27, 2021

The society launched a campaign with the hashtag #ApprovedButDenied protesting the difficulty so many patients have faced attempting to obtain medical cannabis. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? ApprovedButDenied.

Treatment 98

Treatment Patients Access Research and Development 98

CannaMD

JULY 14, 2020

Polypharmacy is a growing problem where patients are prescribed multiple different medications simultaneously in order to treat a given medical condition. It’s often mistakenly believed that taking multiple medications results in better management of a patient’s symptoms, but often that’s simply not the case. WHAT IS POLYPHARMACY?

Marijuana 105

Marijuana Conditions Patients Epilepsy 105

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. ” This isn’t the first time GW Pharmaceuticals is making waves in the cannabis industry. .” “So for that reason, we wanted to apply that to autism.”

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

Cannabis Law Report

JUNE 22, 2021

Following the release of Texas’ first 0:1 THC-only tincture, TOCC’s patient- and doctor-driven lozenges offer balanced treatment to qualifying patients statewide. The CUP caps a product’s legal THC limit at.5% 5% by weight, but does not restrict the amount an individual can consume.

Cultivation 66

Cultivation Tincture Patients Digestion 66

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC. CBD for Anxiety. How to Use Cannabis for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Knowing these can allow you or your healthcare provider to look up the metabolism of a pharmaceutical drug and determine if a CBD-drug interaction is possible. topiramate. rufinamide.

CBD 98

CBD THC Conditions Medicine 98

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” ” State Doctors Oppose Legalization in Alabama.

Legalization 70

Legalization Pharmaceutical Therapy Chronic Pain 70

Veriheal

NOVEMBER 10, 2020

The experiment consists of a two-year cycle where up to 3,000 patients will be treated with medical cannabis. In conjunction with the ANSM, the Ministry of Health and Solidarity will decide on the following: The characteristics, composition, pharmaceutical form, and technical specifications of the medical cannabis products. .

Chronic Pain 72

Chronic Pain Pharmaceutical Patients Epilepsy 72

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Cannabis Law Report

DECEMBER 22, 2019

Cannabis-based medicine is to be fast-tracked into the NHS , allowing thousands of people to be prescribed the drugs, including children with severe epilepsy. Sativex, GW’s cannabis-based medicine for multiple sclerosis, has been rejected because of its high price, to the dismay of patients and campaigners.

Epilepsy 59

Epilepsy Medicine Treatment Pharmaceutical 59

The Cannigma

FEBRUARY 4, 2021

The FDA has approved (separate) drugs with the active ingredients THC and CBD. . Dronabinol, the pharmaceutical name for ?9-tetrahydrocannabinol 9-tetrahydrocannabinol (THC), has been an FDA-approved drug for over 35 years — for chemotherapy-associated nausea, and later for AIDS-related anorexia. grandbrothers/123rf).

THC 145

THC Cannabinoids Blood Pressure Conditions 145

Veriheal

JANUARY 15, 2021

Hemp plants must contain less than 2% THC in order to be considered legal and able to be utilized in the manufacturing of products such as CBD oil. Speaking of CBD, like in the United States, CBD products that are made utilizing industrial hemp are legal as long as they contain less than the legal limit of THC.

Legalization 57

Legalization Therapy Access Legislation 57

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Joint Blog

MAY 28, 2019

One such ailment that has been facing a tough front in terms of medication is Epilepsy. Caused due to abnormal activities in the central nervous system, Epilepsy causes periodic seizures and sensations in individuals who tend to lose a sense of awareness. Cannabis to the rescue. What makes cannabidiol so special?

Oil 42

Oil Epilepsy CBD Treatment 42

The Cannigma

OCTOBER 20, 2021

Since 2018, the Norwegian Medicines Agency allows doctors approved by the agency to prescribe medical cannabis for patients on a case-by-case basis. As of today, the only cannabis-based medication available for patients in Norway is Sativex, though patients can apply to use products like Marinol and Cesamet.

Legalization 59

Legalization Decriminalization Patients Medicine 59

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Bonaventure University and George Washington University School of Medicine. . School: University of Maryland.

Research and Development 117

Research and Development Education Agriculture Patients 117